RadNet raises outlook as Q2 revenue jumps 25%, adjusted EPS beats estimates
RDNT•Raised full-year 2026 outlook
RadNet raised its 2026 Imaging Center revenue guidance to $2.37 billion to $2.42 billion.
It also lifted its 2026 Imaging Center adjusted EBITDA forecast to $345 million to $358 million and reaffirmed 2026 Digital Health revenue guidance at $135 million to $145 million.
Analyst coverage and valuation
The current average analyst rating on the shares is "buy", with 8 "strong buy" or "buy" ratings, no "hold" ratings, and no "sell" or "strong sell" ratings.
The average consensus recommendation for the healthcare facilities and services peer group is "buy".
Wall Street's median 12-month price target for RadNet, Inc. is $93.50, about 29.2% above its Aug. 7 closing price of $72.39.
The stock recently traded at 95 times next 12-month earnings, versus a P/E of 75 three months ago.
